Andrographis Reverses Gemcitabine Resistance through Regulation of ERBB3 and Calcium Signaling Pathway in Pancreatic Ductal Adenocarcinoma.
Biomedicines
; 11(1)2023 Jan 03.
Article
in En
| MEDLINE
| ID: mdl-36672630
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Biomedicines
Year:
2023
Type:
Article
Affiliation country:
United States